Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance
To continue and strengthen effective human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) surveillance programs and to affect, maintain, measure and evaluate the extent of HIV/AIDS incidence and prevalence throughout the United States and its territories, providing information for targeting and implementing HIV prevention activities.
General information about this opportunity
Last Known Status
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Public Health Service Act, Section 301(a)
Who is eligible to apply/benefit from this assistance?
The governments, or their agents or instrumentalities, of any of the States of the United States, the District of Columbia, the Commonwealth of Puerto Rico, territories or possessions of United States, including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and local governments who are current recipients of HIV/AIDS surveillance cooperative agreements.
Official health agencies will benefit.
This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.
What is the process for applying and being award this assistance?
Preapplication coordination is not applicable.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, they may contact the CDC Office of Grants Services Technical Information Management Section (OGSTIMS) staff. For this, or further assistance, contact OGSTIMS: Telephone (770) 488-2700, Email: OGSTIMS@cdc.gov.
After review and approval, a notice of award (NoA) is prepared and processed, along with appropriate notification to the public. Initial award provides funds for first budget period (usually 12 months) and NoA (Form 5152-1) indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 120 to 180 days.
As stated in the Terms and Conditions.
From 120 to 180 days. Renewals may be approved for 1 to 5 years.
How are proposals selected?
(1) Official health agencies which are current recipients of funds for HIV/AIDS surveillance activities; (2) need and background; and (3) a willingness to comply with applicable CDC sero-surveillance protocols.
How may assistance be used?
Grant funds may be used for salaries of staff conducting HIV/AIDS surveillance and sero-surveillance activities, travel related to carrying out project activities and participating in national planning and implementation meetings, necessary supplies, computer software and hardware, and laboratory, data collection, and analysis costs. Grant funds are to be added to replace existing resources.
What are the requirements after being awarded this opportunity?
See NOFO for details.
In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of three years after the end of each budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
From one to five years. Method of awarding/releasing assistance: Letter.
Who do I contact about this opportunity?
Regional or Local Office
1600 Clifton Road, NE, Mailstop E-07
Atlanta, GA 30333 US
(Cooperative Agreements) FY 18$26,150,317.00; FY 19 est $24,166,107.00; FY 20 est $22,879,785.00; FY 17$81,670,365.00; FY 16$78,939,621.00; - PS13-1302; PS15-1503; PS16-1601
Note: For FY 2018, HIV prevention activities and HIV surveillance will be combined into a new project, "Integrated HIV Surveillance and Prevention Programs for Health Departments" (CDC-RFA PS1801802 will combine PS12-1201 and PS13-1301).(Cooperative Agreements) FY 18$25,490,034.00; FY 19 est $21,330,718.00; FY 20 est $22,879,785.00; -
Range and Average of Financial Assistance
Regulations, Guidelines and Literature
PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994; Administration of Grants, DHHS, 45 CFR 92; Application Instructions and Information and Program Guidance established by CDC for HIV/AIDS cooperative agreements.
Examples of Funded Projects